MDT Trading Analysis - 10/16/2026 04:25 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge headlines and context for Medtronic (MDT) that may frame the current data-driven analysis:

• Medtronic reported mixed Q1 FY2026 results in August, with solid device volume growth but persistent pricing pressure in diabetes care.
• Company unveiled next-gen ablation system at a major cardiology conference in September, viewed as a pipeline catalyst.
• FDA cleared a new spine-navigation platform in early October, supporting procedural expansion.
• Management highlighted supply-chain normalization and gross-margin stabilization on last earnings call.
• Declared ex-dividend date of 2026-09-25 with $2.88 annual rate; low beta (0.49) reflects defensiveness vs broader market.

Context: These fundamental and product catalysts align with the embedded technical recovery from September lows and bullish options flow, though news context is kept separate from the data analysis below.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for MDT:

• Trailing P/E: 23.40; Trailing EPS: $4.08; Market Cap: $121.20B; Shares Out: 1.28B.
• Dividend Yield: 3.02% ($2.88 rate); Ex-Dividend: 2026-09-25; Beta: 0.49 (low volatility vs market).
• 52-Week Range: $73.31 - $106.33; Institutional Ownership: 60.11%.
• Average Volume: 33.12M; Historical Volatility: 24.02%.
• PEG Ratio, Forward P/E, Profit Margins, ROE, Debt/Equity, FCF: Not available (null). Revenue growth and margin trends cannot be computed from data.
• Analyst consensus and target price: Not available (null).

Fundamentals show moderate valuation (P/E 23.40) with defensive profile (beta 0.49, dividend 3.02%). Aligns with technical recovery and bullish sentiment, but missing margin/growth data limits deeper divergence analysis.

Current Market Position

Current price per indicators: $95.76 (2026-10-15 close). Minute bars show 2026-10-15 open $95.00, high $95.76, low $93.96, close $95.57; 2026-10-16 last bar (15:55) close $94.78 after intraday range $94.56-$94.78.

Recent daily action: Recovery from 2026-09-30 close $86.42 to 2026-10-15 close $95.76 (+10.83%). Volume on 2026-10-15: 13.60M vs 20-day avg 22.16M (below avg).

Key levels from data: 30-day high $95.94, low $85.22. Bollinger upper $94.83 (price above). SMA_50 $90.69. Support observed near $93.96 (10-15 low) and $90.69 (SMA50). Resistance near $95.94 (30d high) and $106.33 (52w high).

Intraday momentum (10-16): Late-session bounce from $94.56 to $94.78 on rising volume (488K at 15:55), slight positive bias but below 10-15 close.

Technical Analysis

SMA alignment: Price $95.76 > SMA5 $92.44 > SMA20 $89.35 and SMA50 $90.69 (SMA20 below SMA50 = no golden cross, but price above all). No crossovers in window; bullish stacking of price over averages.

RSI 69.08: Approaching overbought (>70) yet strong momentum. MACD 0.65 > signal 0.52, hist +0.13 = bullish continuation. Bollinger: Price $95.76 above upper $94.83 = expansion/breakout. 30-day range: Price at $95.76 near high $95.94 (99.8% of range).

True Sentiment Analysis (Delta 40-60 Options)

Options flow (2026-10-16) methodology: Delta 40-60 only. Sentiment: Bullish

Call Dollar Vol: $1,372,330 (75.9%) Put Dollar Vol: $436,406 (24.1%) Total: $1,808,736

Call contracts 2,921 vs put 916; call trades 30 vs put 16. Pure directional conviction heavily favors calls (75.9% dollar vol), suggesting near-term upside expectations. No divergence from technical bullishness; both align.

Key Price Levels (Observational Only)